A detailed history of Raymond James Financial Inc transactions in Cerus Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 250,170 shares of CERS stock, worth $405,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,170
Previous 233,170 7.29%
Holding current value
$405,275
Previous $328,000 21.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.16 - $1.6 $19,720 - $27,200
17,000 Added 7.29%
250,170 $397,000
Q2 2025

Aug 14, 2025

SELL
$1.22 - $1.51 $5,530 - $6,844
-4,533 Reduced 1.91%
233,170 $328,000
Q1 2025

May 13, 2025

SELL
$1.39 - $2.15 $8,854 - $13,695
-6,370 Reduced 2.61%
237,703 $330,000
Q4 2024

Feb 06, 2025

BUY
$1.52 - $2.03 $370,990 - $495,468
244,073 New
244,073 $375,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.